On November 1, 2018 Novavax, Inc. (Nasdaq:NVAX) reported it will report its third quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, November 7, 2018 (Press release, Novavax, NOV 1, 2018, http://ir.novavax.com/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-financial-1 [SID1234530664]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference call details are as follows:

Date: November 7, 2018
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode: 3639227
Webcast: www.novavax.com, "Investors"/ "Events"
Conference call and webcast replay:

Dates: Starting at 7:30 p.m. ET, November 7, 2018 until
7:30 p.m. ET November 14, 2018
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode: 3639227
Webcast: www.novavax.com, "Investors"/ "Events", until February 7, 2019